Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade
Published inAnnals of the rheumatic diseases, vol. 69, no. 4, p. 706-714
Publication date2010
Abstract
Keywords
- Antirheumatic Agents/adverse effects/*therapeutic use
- Arthritis, Rheumatoid/*drug therapy/immunology/radiography
- Arthroscopy
- Biological Markers/blood/metabolism
- Disease Progression
- Drug Therapy, Combination
- Female
- Humans
- Interleukin 1 Receptor Antagonist Protein/adverse effects/therapeutic use
- Male
- Middle Aged
- Polyethylene Glycols/adverse effects/therapeutic use
- Receptors, Tumor Necrosis Factor, Type I/adverse effects/therapeutic use
- Synovial Membrane/*metabolism
- Treatment Outcome
- Tumor Necrosis Factor-alpha/antagonists & inhibitors
Affiliation
Citation (ISO format)
ROONEY, Terence et al. Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade. In: Annals of the rheumatic diseases, 2010, vol. 69, n° 4, p. 706–714. doi: 10.1136/ard.2009.108324
Main files (1)
Article
Identifiers
- PID : unige:21265
- DOI : 10.1136/ard.2009.108324
- PMID : 19460761
Commercial URLhttp://ard.bmj.com/content/69/4/706.full.pdf
ISSN of the journal0003-4967